In The News Posted March 4, 2019 Share Posted March 4, 2019 SAN JOSE, Calif., March 4, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present its Cchek™ artificial intelligence (AI) based liquid biopsy for the early... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.